Cargando…

Feature and impact of guideline-directed medication prescriptions for heart failure with reduced ejection fraction accompanied by chronic kidney disease

Background: With respect to total mortality and cardiovascular mortality, the feature and impact of guideline-directed medication (GDM) prescriptions for heart failure with reduced ejection fraction (HFrEF) with chronic kidney disease (CKD) are unknown. Therefore, we aimed to determine these aspects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yung-Lung, Hang, Chi-Ling, Su, Chien-Hao, Wu, Po-Jui, Chen, Huang-Chung, Fang, Hsiu-Yu, Fang, Yen-Nan, Cheng, Cheng-I, Fu, Morgan, Chen, Shyh-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176167/ https://www.ncbi.nlm.nih.gov/pubmed/34104088 http://dx.doi.org/10.7150/ijms.55119

Ejemplares similares

The Interrelationship between Ventilatory Inefficiency and Left Ventricular Ejection Fraction in Terms of Cardiovascular Outcomes in Heart Failure Outpatients
por: Chen, Shyh-Ming, et al.
Publicado: (2020)

Optimizing exercise testing‐based risk stratification to predict poor prognosis after acute heart failure
por: Chen, Shyh‐Ming, et al.
Publicado: (2022)

Impact of multi-disciplinary treatment strategy on systolic heart failure outcome
por: Chen, Shyh-Ming, et al.
Publicado: (2019)

Gene Expression Changes of Humans with Primary Mitral Regurgitation and Reduced Left Ventricular Ejection Fraction
por: Tsai, Feng-Chun, et al.
Publicado: (2021)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Optimal Heart Rate Control Improves Long-Term Prognosis of Decompensated Heart Failure with Reduced Ejection Fraction
por: Tsai, Ming-Lung, et al.
Publicado: (2023)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Outcomes of catheter ablation vs. medical treatment for atrial fibrillation and heart failure: a meta-analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2023)

Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction
por: Fillmore, Natasha, et al.
Publicado: (2018)

Device-related infection and mortality in patients with chronic kidney disease receiving cardiac implantable electronic devices: a propensity score-matched cohort study
por: Wu, Po-Jui, et al.
Publicado: (2023)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Prescription patterns of diabetes medications influencing clinical outcomes of heart failure patients with reduced ejection fraction
por: Chang, Hung‐Yu, et al.
Publicado: (2020)

Potentially harmful drug prescription in elderly patients with heart failure with reduced ejection fraction
por: Alvarez, Paulino A., et al.
Publicado: (2020)

The Prescription Pattern of Heart Failure Medications in Reduced, Mildly Reduced, and Preserved Ejection Fractions
por: Rastogi, Tripti, et al.
Publicado: (2022)

Prognosis of patients with heart failure and reduced ejection fraction in China
por: XU, YU, et al.
Publicado: (2013)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Personalized Management for Heart Failure with Preserved Ejection Fraction
por: Lin, Chang-Yi, et al.
Publicado: (2023)

Stress Echocardiography-Derived E/e’ Predicts Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: Chen, Zheng-Wei, et al.
Publicado: (2019)

Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
por: Lin, Yu‐Sheng, et al.
Publicado: (2022)

Association of free fatty acid binding protein with central aortic stiffness, myocardial dysfunction and preserved ejection fraction heart failure
por: Yen, Chih-Hsuan, et al.
Publicado: (2021)

Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
por: Rizzo, M, et al.
Publicado: (2020)

Circulating Monocyte Count as a Surrogate Marker for Ventricular-Arterial Remodeling and Incident Heart Failure with Preserved Ejection Fraction
por: Wang, Kuang-Te, et al.
Publicado: (2020)

Epicardial Adiposity in Relation to Metabolic Abnormality, Circulating Adipocyte FABP, and Preserved Ejection Fraction Heart Failure
por: Lin, Jiun-Lu, et al.
Publicado: (2021)

Development of heart failure with preserved ejection fraction is independent of eosinophils in a preclinical model
por: Pan, Qi, et al.
Publicado: (2023)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Carotid arterial mechanics as useful biomarker of extracellular matrix turnover and preserved ejection fraction heart failure
por: Zhou, Kevin Ning, et al.
Publicado: (2020)

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction
por: Zhou, Yiling, et al.
Publicado: (2021)

Efficacy of guideline‐directed medical treatment in heart failure with mildly reduced ejection fraction
por: Zhang, Xinxin, et al.
Publicado: (2022)

Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction
por: Bak, Minjung, et al.
Publicado: (2023)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
por: Lee, Ying‐Hsiang, et al.
Publicado: (2021)

Relationship between Atrial Tachyarrhythmias and Intrathoracic Impedance in Patients with a Pacemaker and Preserved Ejection Fraction
por: Liao, Min-Tsun, et al.
Publicado: (2019)

Coronary Artery Bypass Graft Surgery Brings Better Benefits to Heart Failure Hospitalization for Patients with Severe Coronary Artery Disease and Reduced Ejection Fraction
por: Chen, Yu-Wen, et al.
Publicado: (2022)

Prognostic Role of Pulmonary Function in Patients With Heart Failure With Reduced Ejection Fraction
por: Chang, Hao‐Chih, et al.
Publicado: (2022)

Malnutrition in acute heart failure with preserved ejection fraction: clinical correlates and prognostic implications
por: Chien, Shih‐Chieh, et al.
Publicado: (2019)

Clinical Response to Personalized Exercise Therapy in Heart Failure Patients with Reduced Ejection Fraction Is Accompanied by Skeletal Muscle Histological Alterations
por: Lelyavina, Tatiana A., et al.
Publicado: (2019)

The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
por: Ren, Qing‐wen, et al.
Publicado: (2020)

Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction: The Misleading Definition of the New Guidelines
por: Fedele, Francesco, et al.
Publicado: (2017)

Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2022)

Frailty interferes with the guideline‐directed medical therapy in heart failure patients with reduced ejection fraction
por: Hamada, Tomoyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rf2lnt5u0vn5i6g2f0rktsti5m